You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR TACHOSIL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for TACHOSIL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00285623 ↗ Observational Cohort Study of TachoSil (TC-018-IN) Completed Nycomed 2005-12-01 The purpose of this study is to collect information, after exposure to TachoSil ®, of all thromboembolic events, immunological events and drug interactions leading to thromboembolic events or major bleeding. In addition, pharmacoeconomic data will be collected.
NCT00293514 ↗ TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM) Completed Nycomed Phase 3 2006-02-01 The purpose of this study is to compare the sealing efficacy and safety of TachoSil® (hereafter referred to as TachoSil) versus standard surgical treatment as the secondary management of intra-operative pulmonary air leakage after a lobectomy in subjects with lung malignancies with or without metastases.
NCT00365248 ↗ TachoSil Paediatric Liver Trial (TC-019-IN) Completed Nycomed Phase 3 2005-10-01 The overall objective is to assess the haemostatic efficacy and safety of TachoSil for control of local bleeding in paediatric patients undergoing surgical resection of the liver with our without segmental liver transplantation.
NCT00440401 ↗ TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM) Completed Nycomed Phase 4 2007-02-01 To demonstrate efficacy and safety of TachoSil® in cardiovascular surgery
NCT00546169 ↗ Non-interventional Trial About Treatment of Haemorrhages in Cholecystectomy With TachoSil (TC-027-DE) Completed Nycomed 2007-06-01 - Effectiveness and reliability of TachoSil in cholecystectomy (elective and acute) - Evaluation of TachoSil in laparoscopic cholecystectomy - Risk profile of patient under anticoagulant therapy undergoing acute cholecystectomy - Pharmaco-economic evaluation - Recording of AE's/SAE's Considering the total number of cholecystectomies in Germany (170.000 cases/y), out of them about 75% laparoscopic and 10.000 conversions totally it seems urgent to record data about usage of TachoSil in such procedures. For the time being TachoSil is applied in about 2% of the gall bladder procedures. Aim is to evaluate a possible patient and procedure profile where TachoSil is most beneficial.
NCT00713661 ↗ Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM) Completed Nycomed Phase 2 2008-06-01 The primary objective is to evaluate if the application of TachoSil® on a colorectal anastomosis is feasible and safe. The secondary objective is to establish and describe optimal application methods to be used for educational purposes in future trials.
NCT00918619 ↗ Efficacy and Safety of Sangustop® as Haemostatic Agent Versus a Carrier-Bound Fibrin Sealant During Liver Resection Completed Aesculap AG Phase 4 2010-01-01 This is a multi-centre, patient-blinded, intra-operatively randomised controlled trial. A total of 126 patients planned for an elective liver resection will be enrolled in 9 surgical centres. The primary objective of this study is to show that the collagen based haemostatic device Sangustop® is not inferior to a carrier-bound fibrin sealant (Tachosil®) in achieving haemostasis after hepatic resection.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for TACHOSIL

Condition Name

Condition Name for TACHOSIL
Intervention Trials
Liver Diseases 2
Cervical Cancer 2
Colorectal Anastomosis 1
Endometrial Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for TACHOSIL
Intervention Trials
Hemorrhage 5
Liver Diseases 2
Blood Loss, Surgical 2
Uterine Cervical Neoplasms 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TACHOSIL

Trials by Country

Trials by Country for TACHOSIL
Location Trials
United States 19
Denmark 5
Germany 4
Austria 3
Netherlands 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for TACHOSIL
Location Trials
West Virginia 1
Massachusetts 1
Arkansas 1
California 1
Colorado 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TACHOSIL

Clinical Trial Phase

Clinical Trial Phase for TACHOSIL
Clinical Trial Phase Trials
Phase 4 6
Phase 3 6
Phase 2 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for TACHOSIL
Clinical Trial Phase Trials
Completed 13
Unknown status 2
Not yet recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TACHOSIL

Sponsor Name

Sponsor Name for TACHOSIL
Sponsor Trials
Nycomed 6
Takeda 2
Asan Medical Center 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for TACHOSIL
Sponsor Trials
Industry 12
Other 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.